|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | -.--% |
GlobeImmune, Inc. (OTCPK:GBIM) announced that it will receive $2,100,000 in funding on March 20, 2017. The company will issue common shares in the transaction. The company will receive $100,000 in cash and securities of aggregate value of $2,000,000 of the investor.
The company will issue securities pursuant to exemption provided under Regulation D.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 5 | |
| +8.63% | 114B | |
| +13.17% | 107B | |
| -12.76% | 22.22B | |
| -2.39% | 21.28B | |
| -4.92% | 18.8B | |
| -7.19% | 17.51B | |
| -39.93% | 17.17B | |
| +6.67% | 14.14B | |
| +33.90% | 12.2B |
GLOBEIMMUNE, INC. 
